MiR-129 reduces CDDP resistance in gastric cancer cells by inhibiting MAPK3.
- DOI
- 10.26355/eurrev_201908_18531
- Published
- 2019 Aug
- Container
- European review for medical and pharmacological sciences
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.26355/eurrev_201908_18531,
title = {MiR-129 reduces CDDP resistance in gastric cancer cells by inhibiting MAPK3.},
author = {Cao HY and Xiao CH and Lu HJ and Yu HZ and Hong H and Guo CY and Yuan JF},
year = {2019},
journal = {European review for medical and pharmacological sciences},
doi = {10.26355/eurrev_201908_18531},
url = {https://doi.org/10.26355/eurrev_201908_18531}
}RIS
TY - JOUR TI - MiR-129 reduces CDDP resistance in gastric cancer cells by inhibiting MAPK3. AU - Cao HY AU - Xiao CH AU - Lu HJ AU - Yu HZ AU - Hong H AU - Guo CY AU - Yuan JF PY - 2019 JO - European review for medical and pharmacological sciences DO - 10.26355/eurrev_201908_18531 UR - https://doi.org/10.26355/eurrev_201908_18531 ER -
APA
HY, C., CH, X., HJ, L., HZ, Y., H, H., CY, G., & JF, Y. (2019). MiR-129 reduces CDDP resistance in gastric cancer cells by inhibiting MAPK3.. European review for medical and pharmacological sciences. https://doi.org/10.26355/eurrev_201908_18531
Source records
- pubmed · retrieved 2026-09-25T06:07:51.026Z